NEW YORK, Jan. 5 (GenomeWeb News) - Shares in Affymetrix were up 6.95 percent at $36.30 in late-afternoon trading after the company said sales during the fourth quarter of 2004 increased 17 percent to more than $100 million.
Affymetrix said that the product-related revenues were a record for the company, and investors flocked to buy the stock. The shares traded as high as $37.24 this morning.
As GenomeWeb News reported this morning, the microarray giant also said it has $10 million worth of orders for products it plans to release within the next six months, including new SNP-genotyping arrays and automated instrumentation.
The company will release its formal financial results on Jan. 26 after the stock market closes.